Envestnet Asset Management Inc. cut its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH – Get Rating) by 8.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 216,551 shares of the company’s stock after selling 21,237 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.21% of Definitive Healthcare worth $2,380,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in the business. Spouting Rock Asset Management LLC lifted its holdings in shares of Definitive Healthcare by 13.4% in the third quarter. Spouting Rock Asset Management LLC now owns 11,010 shares of the company’s stock worth $171,000 after buying an additional 1,298 shares in the last quarter. Steph & Co. lifted its holdings in shares of Definitive Healthcare by 35.5% in the fourth quarter. Steph & Co. now owns 5,619 shares of the company’s stock worth $62,000 after buying an additional 1,471 shares in the last quarter. US Bancorp DE lifted its holdings in shares of Definitive Healthcare by 81.0% in the first quarter. US Bancorp DE now owns 5,087 shares of the company’s stock worth $125,000 after buying an additional 2,276 shares in the last quarter. California State Teachers Retirement System lifted its holdings in shares of Definitive Healthcare by 37.4% in the first quarter. California State Teachers Retirement System now owns 8,679 shares of the company’s stock worth $214,000 after buying an additional 2,361 shares in the last quarter. Finally, Ensign Peak Advisors Inc purchased a new stake in shares of Definitive Healthcare in the third quarter worth about $53,000.
Definitive Healthcare Stock Up 1.9 %
Shares of Definitive Healthcare stock opened at $9.17 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.96 and a current ratio of 2.96. Definitive Healthcare Corp. has a 52-week low of $8.71 and a 52-week high of $30.11. The stock has a market capitalization of $1.01 billion, a price-to-earnings ratio of -76.41, a P/E/G ratio of 24.69 and a beta of 0.51. The company’s 50 day moving average price is $10.47 and its 200-day moving average price is $11.43.
Analyst Ratings Changes
A number of brokerages have recently issued reports on DH. Barclays lowered their price target on shares of Definitive Healthcare from $11.00 to $10.00 in a report on Monday, May 8th. William Blair initiated coverage on shares of Definitive Healthcare in a research report on Wednesday, April 19th. They issued an “outperform” rating on the stock. Morgan Stanley decreased their price objective on shares of Definitive Healthcare from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 28th. Credit Suisse Group decreased their price objective on shares of Definitive Healthcare from $19.00 to $15.00 and set a “neutral” rating on the stock in a research report on Friday, February 24th. Finally, Robert W. Baird decreased their price objective on shares of Definitive Healthcare from $15.00 to $13.00 in a research report on Friday, May 5th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $14.29.
Insider Buying and Selling
In related news, Director Sea Vii Management, Llc sold 6,240 shares of the firm’s stock in a transaction on Friday, May 12th. The stock was sold at an average price of $9.11, for a total value of $56,846.40. Following the completion of the sale, the director now owns 1,743,478 shares of the company’s stock, valued at $15,883,084.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.52% of the stock is currently owned by insiders.
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.
- Get a free copy of the StockNews.com research report on Definitive Healthcare (DH)
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Want to see what other hedge funds are holding DH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. (NASDAQ:DH – Get Rating).
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.